June 27, 2025: Rybelsus Users May Be At Higher Risk of Serious Eye Condition, According to World Health Organization In a WHO safety communication, the organization flagged reports suggesting semaglutide, as used in Ozempic, Rybelsus, and Wegovy, may be associated with a higher risk of non-arteritic anterior ischemic optic neuropathy, or NAION, for those using semaglutide
Some patients may not tolerate the dual-agonist mechanism of tirzepatide
The most effective approach to supporting hair health during this time focuses on consistency: maintaining a nutrient-dense, protein-rich diet, staying hydrated, prioritizing sleep, and managing stress
Initial clinical evidence suggests that GLP-1s may help in three key areas: 1
GLP-1 receptor agonists are medications (such as semaglutide, tirzepatide, and liraglutide) that mimic a natural gut hormone, helping lower blood sugar, reduce appetite, promote weight loss, and decrease inflammation. Can GLP-1 medications help with both diabetes and weight loss